News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗2 briefsClear filters
News
BigHat Biosciences raises USD 75 million in Series C funding
On 2026/9/24, Presspool reported that BigHat Biosciences, a US AI antibody design company, raised USD 75 million in Series C funding, led by DFJ Growth and Premji Invest.
Sep 24, 2026Read brief →
News
BigHat Biosciences raises USD 75 million in Series B financing
Brief not available.
Jul 20, 2022Read brief →